About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Glenmark Receives FDA Approval to Market Generic Montelukast in the US

by Kathy Jones on November 29, 2011 at 7:57 PM
Font : A-A+

 Glenmark Receives FDA Approval to Market Generic Montelukast in the US

Glenmark Pharmaceuticals revealed that it will be marketing generic Montelukast Sodium tablets in the United States from August next year after it received approval by the US Food and Drug Administration to provide the drugs for treating asthma and seasonal allergies.

Glenmark said that it will be manufacturing the tablets after Merck's patent expires in August next year.

Advertisement

The tablets are generic version of the Singulair tablets being sold by Merck with the 10mg strength tablets generating more than $3.2 billion in sales in the last 12 months.

The company also said that it has 73 products available in the US market. Furthermore, it also has over 40 abbreviated new drug applications (ANDAs) that have been submitted to the FDA for approval.

Source: Medindia
Advertisement
Advertisement
Advertisement
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Glenmark Receives FDA Approval to Market Generic Montelukast in the US Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests